These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP. Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535 [Abstract] [Full Text] [Related]
6. Expression of the c-erbB-2 gene product as detected in cytologic aspirates in breast cancer. Allan SM, Fernando IN, Sandle J, Trott PA. Acta Cytol; 1993 Mar; 37(6):981-2. PubMed ID: 7902634 [No Abstract] [Full Text] [Related]
9. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K, Schuurhuis D, Kops GJ, Saceda M, Bates SE. Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [Abstract] [Full Text] [Related]
10. The erbB-3 gene in human pancreatic cancer. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Klöppel G. J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525 [Abstract] [Full Text] [Related]
11. EGF stimulates Pit-1 independent transcription of the human prolactin pituitary promoter in human breast cancer SK-BR-3 cells through its proximal AP-1 response element. Manfroid I, Van de Weerdt C, Baudhuin A, Martial JA, Muller M. Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):127-39. PubMed ID: 15607537 [Abstract] [Full Text] [Related]
12. Regulation of expression and transforming ability of the c-erbB-2 gene. Matsuda S, Akiyama T, Yamada Y, Ishii S, Aizawa S, Mori S, Toyoshima K, Yamamoto T. Princess Takamatsu Symp; 1989 Jan 14; 20():93-101. PubMed ID: 2577338 [Abstract] [Full Text] [Related]
13. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Brysch W, Magal E, Louis JC, Kunst M, Klinger I, Schlingensiepen R, Schlingensiepen KH. Cancer Gene Ther; 1994 Jun 14; 1(2):99-105. PubMed ID: 7621247 [Abstract] [Full Text] [Related]
14. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Zhang M, Maass N, Magit D, Sager R. Cell Growth Differ; 1997 Feb 14; 8(2):179-86. PubMed ID: 9040939 [Abstract] [Full Text] [Related]
15. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. Oncogene; 1994 Feb 14; 9(2):405-15. PubMed ID: 8290253 [Abstract] [Full Text] [Related]
16. The 6-kilobase c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Grooteclaes M, Pasleau F, Dijkmans H, Berzi P, Albert A, Winkler-Gol R. Cancer Res; 1994 Aug 01; 54(15):4193-9. PubMed ID: 7913414 [Abstract] [Full Text] [Related]
17. Ets up-regulates MET transcription. Gambarotta G, Boccaccio C, Giordano S, Andŏ M, Stella MC, Comoglio PM. Oncogene; 1996 Nov 07; 13(9):1911-7. PubMed ID: 8934537 [Abstract] [Full Text] [Related]
19. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T. Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847 [Abstract] [Full Text] [Related]